tm logo
PENCIL BIOSCIENCES
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 22 Nov 2024

Last Applicant/ Owned by

21G1 Mereside Alderley Park

Macclesfield, Cheshire

GB

SK104TG

Serial Number

98450944 filed on 15th Mar 2024

Registration Number

N/A

Correspondent Address

Scott D. Locke

Scott D. Locke Dorf Nelson & Zauderer LLP

Rye, NY 10580

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

PENCIL BIOSCIENCES

Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; genetic engineering services, biotechnology services, advisory services relating to cell therapy and gene therapy products; consultancy and advisory services relating to the aforesaid se Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; genetic engineering services, biotechnology services, advisory services relating to cell therapy and gene therapy products; consultancy and advisory services relating to the aforesaid services.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Therapeutic and prophylactic pharmaceutical products for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; pharmaceutical substances and preparations for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; enzymes and enzyme preparations for medical uses; vectors being gene therapy viral vectors or DNA plasmids for the delivery of genes to cells, all for medical purposes; genetically modified cells for medical use for the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; vectors being gene therapy viral vectors or DNA plasmids for medical use; cell cultures, peptides, proteins, nucleic acids, modified nucleic acids, ribonucleotide protein, mRNA or complexes of these molecules for medical use.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98450944

Mark Type

No Service Mark

Attorney Docket Number

No Pencil 02-US

44D Filed

Yes

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th Nov 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06th Nov 2024APPROVED FOR PUB - PRINCIPAL REGISTER
04th Nov 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
04th Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
04th Nov 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
26th Sep 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
26th Sep 2024NON-FINAL ACTION WRITTEN
26th Sep 2024NON-FINAL ACTION E-MAILED
25th Sep 2024ASSIGNED TO EXAMINER
08th Aug 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED